Business

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare

articlePrecigen, Inc.May 26, 20265/company/precigen-inc/news/precigen-to-participate-in-fireside-chats-with-jp-morgan-and-at-the-goldman-sachs-47th-annual-global-healthcare-conference
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

About this update from Precigen, Inc.

[{"type":"text","content":"GERMANTOWN, Md., May 26, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the company will participate in two upcoming investor events.The J.P. Morgan virtual fireside chat will be held on Monday, June 1, at 10:00 a.m. ET. The event will be hosted by Brian Cheng, Senior Biotech Analyst, J.P. Morgan. Precigen participants will include Helen Sabzevari, PhD, President and CEO, and Phil Tennant, Chief Commercial Officer.The Goldman Sachs 47th Annual Global Healthcare Conference will be held from June 8 to 10, 2026, in Miami Beach, Florida. Helen Sabzevari, PhD, President and CEO, Precigen, will participate in a fireside chat on Monday, June 8, at 9:20 a.m. ET.Participants may view details for these events on Precigen's website in the Events & Presentations section at investors.precigen.com/events-presentations.Precigen: Advancing Medicine with Precision®Precigen (Nasdaq: PGEN) is a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization. With a strong commitment to innovation, Precigen is developing a robust pipeline of differentiated therapies across its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. For more information about Precigen, visit www.precigen.com or follow us on LinkedIn or YouTube.Cautionary Statement Regarding Forward-Looking StatementsThis press release contains \"forward-looking\" statements within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: \"anticipate,\" \"intend,\" \"plan,\" \"goal,\" \"seek,\" \"believe,\" \"project,\" \"estimate,\" \"expect,\" \"strategy,\" \"future,\" \"likely,\" \"may,\" \"should,\" \"will\" and similar references to future periods. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what the Company expects. Examples of forward-looking statements include...

More updates from Precigen, Inc.